glimepiride has been researched along with c-peptide in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 16 (43.24) | 29.6817 |
| 2010's | 9 (24.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badian, M; Komjati, M; Korn, A; Malerczyk, V; Ratheiser, K; Vierhapper, H; Waldhäusl, W | 1 |
| Gudat, U; Heinemann, L | 1 |
| Badian, M; Korn, A; Lehr, KH; Malerczyk, V; Waldhäusl, W | 1 |
| Muchmore, DB; Rosenstock, J; Samols, E; Schneider, J | 1 |
| Dills, DG; Schneider, J | 1 |
| Clark, HE; Matthews, DR | 1 |
| Herz, M; Massi-Benedetti, M; Pfeiffer, C | 1 |
| Bowen, AJ; DeChemey, GS; Dixon, RM; Garg, DC; Jaber, LA; Mullican, WS; Sonnenberg, GE; Stonesifer, LD; Weidler, DJ | 1 |
| Aarsen, M; Draeger, KE; Heine, RJ; Martini, C; van der Wal, PS; van Iperen, AM | 1 |
| Riddle, MC; Schneider, J | 1 |
| Jovanovic, L; Schade, DS; Schneider, J | 1 |
| Dimitriadis, G; Draeger, KE; Hatziagelaki, E; Pfeiffer, C; Raptis, AE; Raptis, SA | 1 |
| Gomis, R; Raptis, SA; Ravella, R | 1 |
| Abbink, EJ; Jansen van Rosendaal, A; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ | 1 |
| Gerich, J; Gooding, WE; Korytkowski, M; Reid, L; Tedesco, MB; Thomas, A | 1 |
| Häring, HU; Heide, PE; Maerker, E; Overkamp, D; Rett, K; Volk, A; Wahl, HG | 1 |
| Earle, KE; Goldfine, ID; Rushakoff, RJ | 1 |
| de Boer, H; Jansen, M; Koerts, J; Verschoor, L | 1 |
| Bielesz, GK; Egger, T; Feinböck, C; Frank, E; Grossschädl, F; Irsigler, K; Klingler, A; Luger, A; Siebenhofer, A; Winkler, F | 1 |
| Barbieri, M; Barone, M; Grella, R; Paolisso, G; Passariello, N; Rizzo, MR | 1 |
| Komiya, I; Kouki, T; Nakachi, A; Takasu, N; Tamanaha, T; Tawata, M | 1 |
| Fukui, M; Hasegawa, G; Hirata, C; Ichida, Y; Ichio, N; Kadono, M; Kitagawa, Y; Mogami, S; Nakajima, T; Nakamura, N; Onishi, M; Ose, H; Yoshikawa, T | 1 |
| Cryer, PE; Fender, AB; Gerich, JE; Gosmanov, NR; Meyer, C; Nihalani, A; Sinkin, JC; Szoke, E | 1 |
| Issa, M; Lake, B; Melis, R; Roberts, VL; Stewart, J | 1 |
| Abdollahnia, MR; Forst, T; Kaiser, M; Kann, PH; Lorra, B; Mathieu, D; Oligschleger, C; Pehnert, C; Pfützner, A | 1 |
| Kaku, K; Kanda, Y; Kawasaki, F; Kohara, K; Kotani, K; Matsuda, M; Matsuki, M; Shigetoh, M; Shimoda, M; Tawaramoto, K | 1 |
| Eliaschewitz, FG; Hayashida, CY; Kawamori, R; Takayama, H | 1 |
| Cooperberg, BA; Cryer, PE | 1 |
| Bremer, AA; Jame, M; Loomba-Albrecht, LA | 1 |
| Haneda, M; Honjo, J; Sone, H; Yamada, D; Yokoyama, H | 1 |
| Arbeláez, AM; Cryer, PE; Ramanathan, RP | 1 |
| Bell, DS; Dharmalingam, M; Kumar, S; Sawakhande, RB | 1 |
| Arai, K; Hirao, K; Hirao, S; Hirao, T; Maeda, H; Sirabe, S; Yamamoto, R; Yamauchi, M | 1 |
| Fujioka, Y; Inoue, K; Izawa, S; Kato, M; Matsuzawa, K; Nakanishi, R; Ohkura, H; Ohkura, T; Shiochi, H; Sumi, K; Taniguchi, S; Yamamoto, K; Yamamoto, N | 1 |
| Bhattacharya, S; Boehm, BO; Grill, V; Johansen, OE; Patel, S; Torjesen, PA; Wetzel, K; Woerle, HJ | 1 |
| Ha, KS; Lee, HC; Lee, HW; Moon, JS; Won, KC; Yoon, JS | 1 |
| Davis, SN; Joy, NG; Tate, DB | 1 |
30 trial(s) available for glimepiride and c-peptide
| Article | Year |
|---|---|
Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Male; Sulfonylurea Compounds | 1993 |
Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].
Topics: Adult; Blood Glucose; C-Peptide; Exercise; Exercise Test; Female; Glucagon; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Lactates; Lactic Acid; Male; Sulfonylurea Compounds | 1996 |
Pharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administration.
Topics: Adolescent; Adult; Area Under Curve; Biotransformation; Blood Glucose; C-Peptide; Half-Life; Humans; Hydroxylation; Hypoglycemic Agents; Injections, Intravenous; Insulin; Male; Single-Blind Method; Sulfonylurea Compounds | 1996 |
Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Sulfonylurea Compounds; Time Factors | 1996 |
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1996 |
The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Clamp Technique; Glyburide; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Placebos; Sulfonylurea Compounds | 1996 |
The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1996 |
Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Sulfonylurea Compounds | 1997 |
Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Middle Aged; Pharmaceutical Preparations; Proinsulin; Sulfonylurea Compounds | 1997 |
Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Patient Dropouts; Sulfonylurea Compounds; Treatment Outcome; Triglycerides | 1998 |
A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet Therapy; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Sulfonylurea Compounds | 1998 |
Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Double-Blind Method; Fasting; Food; Glyburide; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Middle Aged; Placebos; Sulfonylurea Compounds | 1999 |
Appropriate timing of glimepiride administration in patients with type 2 diabetes millitus: a study in Mediterranean countries.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Placebos; Prospective Studies; Sulfonylurea Compounds; Time Factors | 2000 |
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Double-Blind Method; Female; Forearm; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Vasodilation | 2002 |
Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds | 2002 |
Prospective multicentre trial comparing the efficacy of, and compliance with, glimepiride or acarbose treatment in patients with type 2 diabetes not controlled with diet alone.
Topics: Acarbose; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Patient Compliance; Sulfonylurea Compounds | 2003 |
Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study.
Topics: Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Middle Aged; Piperidines; Postprandial Period; Sulfonylurea Compounds; Time Factors; Triglycerides | 2004 |
Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucose; Glyburide; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Kinetics; Male; Sulfonylurea Compounds | 2006 |
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors | 2005 |
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucose Oxidase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin-Secreting Cells; Male; Middle Aged; Proinsulin; Sulfonylurea Compounds | 2006 |
Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing.
Topics: Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 2007 |
Efficacy of insulin glargine and glimepiride in controlling blood glucose of ethnic Japanese patients with type 2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Japan; Male; Middle Aged; Sulfonylurea Compounds | 2008 |
Contribution of glimepiride to basal-prandial insulin therapy in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin, Long-Acting; Male; Middle Aged; Sulfonylurea Compounds | 2011 |
Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
Topics: Adult; Blood Glucose; C-Peptide; Diazoxide; Female; Glucagon; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; KATP Channels; Male; Sulfonylurea Compounds; Young Adult | 2011 |
Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II).
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Patient Satisfaction; Pioglitazone; Postprandial Period; Prospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2011 |
Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Triazoles | 2013 |
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Hypoglycemic Agents; Insulin; Isoindoles; Male; Middle Aged; Molecular Targeted Therapy; Postprandial Period; Proinsulin; Sulfonylurea Compounds; Triglycerides | 2013 |
C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Topics: Adult; Aged; Autoimmunity; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Sulfonylurea Compounds | 2014 |
The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Republic of Korea; Sulfonylurea Compounds; Young Adult | 2014 |
Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Leptin; Male; Pancreatic Polypeptide; Single-Blind Method; Sulfonylurea Compounds | 2015 |
7 other study(ies) available for glimepiride and c-peptide
| Article | Year |
|---|---|
Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Metabolic Clearance Rate; Nuclear Family; Reference Values; Sulfonylurea Compounds | 2002 |
Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
Topics: Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Overdose; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds | 2003 |
Prevention of weight gain in type 2 diabetes requiring insulin treatment.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pilot Projects; Sulfonylurea Compounds; Weight Gain | 2004 |
Low-dose metformin improves hyperglycaemia related to myotonic dystrophy.
Topics: Blood Glucose; C-Peptide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Middle Aged; Myotonic Dystrophy; Sulfonylurea Compounds | 2005 |
Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Retrospective Studies; Sulfonylurea Compounds | 2005 |
Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Eating; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Secreting Cells; Homeostasis; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Reference Values; Signal Transduction; Sulfonylurea Compounds | 2009 |
A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
Topics: Adolescent; Area Under Curve; Blood Glucose; C-Peptide; Child, Preschool; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Glucokinase; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Male; Mutation; Sulfonylurea Compounds | 2010 |